Genetic cystic fibrosis transmembrane regulator 4016insT D1152H compound heterozygosity and male infertility: an Italian case report

Articles in the same Issue

1. Pharmacogenomics and Personalized Medicine – a global reality check
2. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice
3. Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy
4. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
5. Effect of 13-cis-retinoic acid on the genetic expression profile of human umbilical vein endothelial cells (HUVECs) determined by microarray
6. Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs
7. A1166C polymorphism of the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment
8. Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”
9. On detecting interference from endogenous antibodies in immunoassays by doubling dilutions test
10. High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes
11. Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience
12. A novel application of melting curves: utility of peak area calculation for relative methylation quantification
13. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians
14. Tumor necrosis factor-α and oxidant status are essential participating factors in unexplained recurrent spontaneous abortions
15. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of β-thalassemia/hemoglobin E patients
16. Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients
17. Direct determination of selenium in human serum by inductively coupled plasma-collision cell-mass spectrometry
18. Within-subject variation of plasma resistin levels over a 1-year period
19. Global DNA methylation measured by liquid chromatography-tandem mass spectrometry: analytical technique, reference values and determinants in healthy subjects
20. Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population
21. Comparison of the Roche COBAS Amplicor™ Monitor, Roche COBAS Ampliprep™/COBAS Taqman™ and Abbott RealTime™ Test assays for quantification of hepatitis C virus and HIV RNA
22. Genetic cystic fibrosis transmembrane regulator 4016insT D1152H compound heterozygosity and male infertility: an Italian case report
23. Reference intervals for serum cystatin C in healthy Mexican adults
24. Could standard ISO 15189 be useful for the conundrum of CA 19-9/GI Monitor measurement?
25. Quality control strategy to verify day-to-day imprecision of length of blood sedimentation reaction measurements with the TEST-1 analyzer
26. Applicability of α-fetoprotein-concanavalin A (AFP-ConA) binding to discriminate between germinal or hepatic origin of AFP in germ cell tumour patients during chemotherapy or follow-up
27. Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum
28. Balkan Clinical Laboratory Federation − past, present and future trends